Who owns the VITAL CHOICE trademark?

The VITAL CHOICE trademark is owned by MEAD JOHNSON & COMPANY.

What class is the VITAL CHOICE trademark registered in?

The VITAL CHOICE trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for VITAL CHOICE?

The USPTO serial number for VITAL CHOICE is 75296912.

What is the registration number for VITAL CHOICE?

VITAL CHOICE is registered under USPTO registration number 0.

Sealvo

Home Search: VITAL CHOICEVITAL CHOICE #75296912

Back

Updated Sep 23, 2026·8 searches this week

View on USPTO TSDR Find similar marks

VIT

USPTO Trademark Record

ABANDONED

VITAL CHOICE

SN 75296912·Reg 0·Filed May 16, 1997

Owner MEAD JOHNSON & COMPANY

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

VITAL CHOICE (Serial No. 75296912), Registration No. 0, is a abandoned US trademark filed on May 16, 1997 by MEAD JOHNSON & COMPANY. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Conflict Analysis

Full conflict analysis for VITAL CHOICE (SN 75296912) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

VITAL CHOICE (Reg. #0) is an abandoned US trademark that was filed in 1997 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

May 16, 1997

SERIAL

75296912

REG#

REGISTERED

Dec 31, 1969

Filing Information

StatusABANDONED

Filing DateMay 16, 1997

Serial Number75296912

Registration No.0

Registration DateDec 31, 1969

Status DateMar 23, 1999

Published for OppositionMar 31, 1998

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

7 events

ABANDONMENT - NO USE STATEMENT FILED

May 20, 1999

ABANDONMENT - NO USE STATEMENT FILED

NOA MAILED - SOU REQUIRED FROM APPLICANT

Sep 22, 1998

NOA MAILED - SOU REQUIRED FROM APPLICANT

EXTENSION OF TIME TO OPPOSE RECEIVED

Apr 17, 1998

EXTENSION OF TIME TO OPPOSE RECEIVED

PUBLISHED FOR OPPOSITION

Mar 31, 1998

PUBLISHED FOR OPPOSITION

NOTICE OF PUBLICATION

Feb 27, 1998

NOTICE OF PUBLICATION

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 05, 1998

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Dec 22, 1997

ASSIGNED TO EXAMINER

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

VIT

VITAL CHOICE

78464550

1-800-FLOWERS.COM, INC.

REGISTERED

VIT

VITAL

86168258

Homestead Nutrition, Inc.

REGISTERED

VIT

VITAL

76353621

LUXEMBOURG INDUSTRIES LTD.

REGISTERED

VIT

VITAL

73160318

ABBOTT LABORATORIES

REGISTERED

Other Marks by NADINE P FLYNN

Additional USPTO filings handled by the same attorney of record.

IXE

IXEMPLE A PHASE III OPEN LABEL, RANDOMIZED, 2 ARM STUDY OF IXABEPILONE ADMINISTERED EVERY 21 DAYS VERSUS PACLITAXEL OR DOXORUBICIN ADMINISTERED EVERY 21 DAYS IN WOMEN WITH ADVANCED ENDOMETRIAL CANCER WHO HAVE PREVIOUSLY BEEN TREATED WITH CHEMOTHERAPY

77775355

OTHERS

IXA

IXAMPLE A PHASE III OPEN LABEL, RANDOMIZED, 2 ARM STUDY OF IXABEPILONE ADMINISTERED EVERY 21 DAYS VERSUS PACLITAXEL OR DOXORUBICIN ADMINISTERED EVERY 21 DAYS IN WOMEN WITH ADVANCED ENDOMETRIAL CANCER WHO HAVE PREVIOUSLY BEEN TREATED WITH CHEMOTHERAPY

77775341

OTHERS

IXA